Unsafe blood and unkept promises: Experts suggest mandatory NAT at all blood banks
Tired of too many ads? go ad free now
"I wasn't recovering. After several tests, they told me I was HIV-positive. I suspect it came from a transfusion. If the blood was properly tested, maybe this wouldn't have happened," she said.
Now living with both thalassemia and HIV, she depends not only on regular transfusions, but also on antiretroviral treatment.
The woman's testimony at the roundtable on "Ensuring Safe Blood for All: Strengthening Blood Safety Practices", organised by the Thalassemia Patients Advocacy Group (TPAG) at India International Centre on Thursday, brought into sharp focus the urgent need to fix India's blood safety ecosystem.
Experts at the event called for comprehensive reforms — from mandatory nucleic acid testing (NAT) at all blood banks to boosting voluntary blood donation and patient participation in policymaking. NAT, which detects HIV, Hepatitis B and Hepatitis C during the early infection "window period", is far more effective than standard tests, but is not yet mandatory across India.
"Safe blood is not just about testing — it begins at the source," said Dr Sangeeta Pathak, secretary general of Indian Society of Blood Transfusion & Immunohematology (ISBTI) and head of Transfusion Medicine at Max Saket. "Voluntary, non-remunerated blood donation is key. Sri Lanka has achieved 100% voluntary donation. Why not India?"
She called on both professionals and the public to take ownership.
"We must talk about it, promote it, and strengthen the culture of safe, voluntary blood donation."
Anubha Taneja Mukherjee, member secretary, TPAG, reminded participants that blood safety is a matter of human rights. "This isn't just a technical issue. It's about dignity, equity, and the right to safe, life-saving interventions."
Public health advocate Prof Bejon Kumar Misra emphasised the need for transparency and accountability.
Tired of too many ads? go ad free now
"Safety is non-negotiable. People have a right to know what is being done — and what's not. Communication is critical. We need strategies that ensure no patient falls through the cracks."
P C Sen, senior Supreme Court advocate, reiterated the state's legal obligation to ensure access to pathogen-free blood. "It's not just a public health concern. It's constitutional."
BJP spokesperson Tuhin A Sinha assured the gathering of govt's commitment to stronger frameworks and cross-sector collaboration.
"This is not a single-agency issue. It requires everyone — govt, civil society and experts — coming together to strengthen the system," he said.
Prof N K Ganguly, former DG of ICMR, highlighted the need for investment in diagnostics, better regulation, and scaling up innovations.
The roundtable brought together perspectives from medicine, law, advocacy and governance, each viewing the issue through a different lens but advocating a unified message — that blood safety must be treated as foundational to India's healthcare transformation, not as a peripheral challenge.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
30 minutes ago
- Hindustan Times
Liver specialist explains how hepatitis affects women; tips and tests every woman should know for early detection
The World Health Organisation (WHO) has defined hepatitis as an inflammation of the liver that is caused by a variety of infectious viruses and non-infectious agents, leading to a range of health problems, including severe liver damage and cancer, some of which can be fatal. There are 5 main strains of the hepatitis virus, referred to as types A, B, C, D and E. Many women are unaware of how Hepatitis B spreads—via blood, unsafe sex, or from mother to child—often mistaking it for a lifestyle-related or liver-specific issue alone. (Shutterstock) Also Read | Gastroenterologist lists 8 groups of people who are at higher risk; shares when to get tested WHO data says that types B and C lead to chronic disease in hundreds of millions of people, and an estimated 1.3 million deaths per year. According to the World Hepatitis Alliance, globally, women face more challenges in accessing quality health services due to sociocultural and economic factors and discrimination. Therefore, it becomes necessary to educate them about this disease. Hepatitis and the problems faced by women In an interview with HT Lifestyle, Dr Jignesh Patel, gastroenterologist and liver specialist, HCG Hospitals, Ahmedabad, stressed that hepatitis B remains a serious yet preventable public health issue in India. While women form the backbone of families and communities, their awareness and protection against Hepatitis B often remain inadequate. The gap is not just in healthcare access, but in education, screening, and social perception. Without targeted screening, many individuals - especially women - do not realise that they are infected until the disease has progressed and caused serious liver damage. (Freepik) According to Dr Vikram Vora, medical director, International SOS (India), hepatitis infections, especially hepatitis B and C, can remain asymptomatic for years. He stressed, 'Without targeted screening, many individuals - especially women juggling multiple roles, who are unable to focus on their own health and wellbeing - do not realise that they are infected until the disease has progressed and caused serious liver damage, including fibrosis, cirrhosis or hepatocellular carcinoma.' 'This culturally ingrained self-neglect means symptoms, when they appear, may be brushed aside or misattributed to stress or hormonal changes. In working women, this can be even more pronounced due to the complex interplay of occupational, social, and biological factors,' he added. What stops early detection in women 1. Lack of Awareness 'Many women are unaware of how Hepatitis B spreads—via blood, unsafe sex, or from mother to child. It is often mistaken for a lifestyle-related or liver-specific issue alone,' Dr Patel explained. 'Working women often operate under significant time pressure, regardless of whether they work in formal or informal sectors. Between managing household responsibilities and professional demands, preventive health checkups end up being deprioritised. Although corporate wellness programs have started to focus on non-communicable diseases (like diabetes and hypertension), rarely do they include hepatitis screening,' Dr Vora added. 2. Inadequate Screening Per Dr Patel, a simple blood test, S. HBsAg, is enough to screen for Hepatitis B. 'This test should be strongly recommended for all women, especially before pregnancy, to detect infection early and prevent transmission to the child,' he said. However, clinics often operate during standard working hours, and relatively few employers offer on-site testing or flexible leave for preventive health services. 'This creates a vicious cycle of low awareness, low testing and consequently, late diagnosis,' Dr Vora explained. 3. Vaccination Gaps 'While childhood vaccination is part of India's Universal Immunisation Program, adult women—particularly in reproductive age—often miss out on catch-up vaccination, putting them at avoidable risk,' Dr Patel explained. Dr Vora added, 'Despite the availability of effective hepatitis B vaccines and curative treatments for hepatitis C, awareness remains low. Many women are unaware of their vaccination status or the need for screening, especially if they were born before hepatitis B vaccination was included in national immunisation programs.' Tattoos can be a hidden threat if done at unlicensed parlours with non-sterile equipment. (Freepik) 4. Unsafe Practices: Hepatitis is also compounded by social stigma, largely due to its association with sexual transmission or drug use, Dr Vora emphasised. 'Even educated women may feel hesitant to seek testing or disclose their status for fear of being misunderstood, judged, or discriminated against in the workplace,' he explained. Therefore, safe sex practices must be emphasised, especially among young adults, per Dr Patel. 'Tattoos, which are increasingly popular among younger women as a form of self-expression, can be a hidden threat if done at unlicensed parlours with non-sterile equipment. Tattooing with contaminated needles is a known route for Hepatitis B transmission,' he added. 5. Stigma and Silence: Dr Patel explained, 'There is a hesitation to undergo screening or discuss Hepatitis B openly due to the associated stigma. This social silence delays diagnosis and care.' Tips and tests women should know about early detection Here are some key things to remember, as per Dr Patel: Routine Hepatitis B screening (S. HBsAg)should be made a standard part of pre-marital and pre-pregnancy health checks. Promote vaccination for all unvaccinated women as part of preventive health campaigns. Educate women on transmission routes and the importance of safe sex and safe body art practices. Conduct awareness drives in schools, colleges, and workplaces to normalise conversations around liver health and Hepatitis B. Providenon-judgmental clinical environments where women feel safe to seek testing and treatment. Workplace awareness Lastly, Dr Vora highlighted how hepatitis education is often absent from workplace wellness communications. 'Without targeted information campaigns, the average working woman remains unaware of the long-term risks of chronic hepatitis or the ease of getting screened with a simple blood test,' he stated. To bridge this gap, Dr Vora suggested a need for comprehensive and gender-sensitive workplace health and wellness policies: Awareness: Constant availability of health information from credible and medically validated sources. Screening and Education: Ensuring workplace testing or the provision of access to external screening. Destigmatization: An open culture where discussions around health conditions are free and frank without prejudice Engagement: Using digital enablement and fostering a sense of community. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Hindustan Times
30 minutes ago
- Hindustan Times
Hepatitis E is the primary cause of acute hepatitis: Study
MUMBAI: The monsoon tends to see a rise in cases of acute hepatitis, a liver infection accompanied by fever, fatigue, loss of appetite, nausea, abdominal pain and jaundice-like symptoms. Now, researchers from the civic-run Nair and Kasturba hospitals have identified Hepatitis E as the primary cause of acute hepatitis infections, in a study published in the Medical Journal of Viral Hepatitis. Hepatitis E is the primary cause of acute hepatitis: Study The study analysed data from 2,488 patients from Mumbai and other parts of Maharashtra being treated at Kasturba Hospital, across three years. The researchers concluded that Hepatitis E accounted for 52.65% of acute cases, followed by Hepatitis A at 22.18%, and Hepatitis B at 10.56%. In all age categories, Hepatitis E accounted for the majority of cases. Overall, 66.1% of the patients studied were male, with the highest incidence observed among individuals aged 18 to 30 years. The study, published in January, was conducted by Dr Pravin Rathi and other doctors from the gastroenterology department of Nair Hospital, along with Dr Chandrakant Pawar from the infectious diseases department of Kasturba Hospital. The research focused on patients primarily from Mumbai and its outskirts, many belonging to economically weaker sections. Hepatitis E spreads through contaminated food and water, which is why cases of acute hepatitis rise during the monsoon. These conditions, as well as unsanitary conditions including the accumulation of sewage in open spaces, facilitates its spread. 'Acute hepatitis is a major public health issue in low middle-income countries like India¸ where there is also a significant under-reporting of instances. The precise global illness burden of acute hepatitis is unknown. Even though the majority of these individuals have viral hepatitis, autoimmune hepatitis and drug-induced liver injury are on the rise as a result of urbanisation and greater knowledge of these conditions,' said the researchers. While Hepatitis A and E spread through contaminated water and food, B, C and D spread through blood and body fluids and can cause severe complications including cirrhosis, liver cancer and liver failure. The researchers also observed that with advancing age, the prevalence of Hepatitis A and E declined, and, on the contrary, the prevalence of hepatitis B and hepatitis C increased with age. 'Although 98% of acute hepatitis cases tend to recover, the remaining 2% are at risk of liver failure or cirrhosis, necessitating urgent liver transplant. The infection poses significant risks to pregnant women, with high mortality rates reported for both mothers and fetuses,' said Dr Rathi, head of the gastroenterology department at Nair Hospital. He explained that Hepatitis E can cause liver inflammation, which often resolves itself. However, individuals with weakened immune systems can develop acute symptoms and are at higher risk of developing complications. 'Gastrointestinal bleeding, anemia, low serum albumin, and presentations as acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) are independent predictors of mortality in acute hepatitis patients. Pruritus, an uncomfortable sensation leading to itchy skin, was observed in about 30% of patients with Hepatitis E, commonly associated with cholestasis (obstruction to the flow of bile), a consequence of the infection,' read the study. In the study, the researchers noted a decline in Hepatitis C cases, attributing this to the availability of effective antiviral treatments. 'Consuming clean water, either by boiling or using purifiers, ensuring no cross-contamination between sewage and drinking water pipelines, and avoiding street food, especially during summer and monsoon seasons is important.
Time of India
2 hours ago
- Time of India
3 in 5 liver cancer cases are preventable, experts reveal
A recent study in The Lancet reveals that 60% of liver cancer cases are preventable by addressing risk factors like viral hepatitis, alcohol consumption, and metabolic dysfunction-associated steatotic liver disease (MASLD). Experts predict a significant rise in MASLD-related liver cancer by 2050, particularly among those with diabetes and obesity. In 2020, about 905,700 people were diagnosed with liver cancer, and 830,200 people died from it. It remains the top three causes of death in many countries. With the incidence of liver diseases on the rise, the numbers could further surge. However, a new study has found that most of the liver cancer cases are preventable. According to a new analysis published in The Lancet , 3 in 5 liver cancer cases are preventable. This is more than 60% of liver cancer cases worldwide. 60% of the liver cancer cases are preventable (Pic courtesy: iStock) The new study found that three in five liver cancer cases are preventable through the reduction of risk factors, including viral hepatitis, alcohol, and metabolic dysfunction-associated steatotic liver disease (MASLD), a long-term liver condition caused by excess fat in the liver. The study on liver cancer predicts that by 2050, liver cancer cases caused by a severe form of MASLD, known as MASH, will rise by 35%, from 8% to 11%. The authors have emphasized the importance of creating public, medical, and political awareness of the rising risk of MASLD, especially in the USA, Europe, and Asia. People with diabetes and obesity are especially at risk. According to the study, new liver cancer cases are predicted to double in the next 25 years if the cause is not addressed. The Commission also suggested that the risk factors can be reduced in several ways, such as increasing the coverage of the hepatitis B vaccine and public health policies that target obesity and alcohol consumption. Previous analyses have predicted that new liver cancer cases will almost double, from 870,000 in 2022 to 1.52 million by 2050, mainly due to population growth and ageing. The biggest rise is expected in Africa. Deaths from liver cancer are projected to increase from 760,000 in 2022 to 1.37 million by 2050. As liver cancer remains a major cause of death and disability, looking at the risk factors is crucial. It is the sixth most common cancer and the third leading cause of death globally. More than 40% of the global liver cancer cases occur in China, mostly due to relatively high rates of hepatitis B infections in the country. 'Liver cancer is a growing health issue around the world. It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5% to 30%. We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend,' Chair of the Commission, Prof Jian Zhou, Fudan University (China) said in a statement. 'As three in five cases of liver cancer are linked to preventable risk factors, mostly viral hepatitis, alcohol and obesity, there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer and save lives,' first author, Prof Stephen Chan, Chinese University of Hong Kong (Hong Kong, China) added. Shift in the cause of liver cancer The study stressed that at least 60% of liver cancers are preventable by controlling modifiable risk factors, including hepatitis B virus (HBV), hepatitis C virus HCV, MASLD, and alcohol. The researchers noted that MASLD is a rising risk. Approximately a third of the global population are estimated to have MASLD. However, only 20 to 30% of patients with MASLD develop the more severe form of the condition, with liver inflammation and damage, called metabolic dysfunction-associated steatohepatitis (MASH). The incidence of MASLD-linked liver cancer is expected to go up in the next 10 years, with obesity being the key driver. 'Liver cancer was once thought to occur mainly in patients with viral hepatitis or alcohol-related liver disease. However, today rising rates of obesity are an increasing risk factor for liver cancer, primarily due to the increase in cases of excess fat around the liver. One approach to identify patients at high risk of liver cancer would be to introduce screening for liver damage into routine healthcare practice for patients at high risk of MASLD, such as individuals living with obesity, diabetes, and cardiovascular disease. Healthcare professionals should also integrate lifestyle counselling into routine care to support patients to transition to a healthy diet and regular physical activity. Furthermore, policy makers must promote healthy food environments via policies such as sugar taxes and clear labelling on products with high fat, salt, and/or sugar,' commission author, Prof Hashem B El-Serag, Baylor College of Medicine (USA) said. What can be done According to the commission, if the incidence of liver cancer cases can be reduced by 2 to 5% each year by 2050, it could prevent nine to 17 million cases of liver cancer and save eight to 15 million lives. As more patients live with liver cancer than ever before, in addition to prevention efforts, there is an urgent need for increased research and attention for these patients to improve their quality of life. Supreme Court Pushes Central Govt to Finalise FOPL: What It Means & Why It Matters? | Explained 'There is an urgent need to raise awareness within society about the severity of the growing health issue of rising liver cancer cases. Compared with other cancers, liver cancer is very hard to treat but has more distinct risk factors, which help define specific prevention strategies. With joint and continuous efforts, we believe many liver cancer cases can be prevented and both the survival and quality of patients with liver cancer will be considerably improved,' Commission author, Prof Valérie Paradis, Beaujon Hospital (France) said.
